Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| PG 106 | N-Acetyl-L-norleucyl-L-alpha-aspartyl-beta-alanyl-3-(2-naphthalenyl)-D-alanyl-L-arginyl-L-tryptophyl-L-Lysinamide(2→7)-lactam; Ac-Nle-cyclo(-Asp-beta-Ala-D-2-Nal-Arg-Trp-Lys)-NH2; ((1H-Indol-3-yl)methyl)-16-(2-acetamidohexanamido)-6-(3-guanidinopropyl)-9-(naphthalen-2-ylmethyl)-2,5,8,11,15,18-hexaoxo-1,4,7,10,14,19-hexaazacyclotetracosane-24-carboxamide | 944111-22-2 | C51H69N13O9 | 1008.18 | N-Acetyl-L-norleucyl-L-alpha-aspartyl-beta-alanyl-3-(2-naphthalenyl)-D-alanyl-L-arginyl-L-tryptophyl-L-Lysinamide(2→7)-lactam; Ac-Nle-cyclo(-Asp-bet... |
| PGD-M | (1R,2R,3S,5S)-2-[(2Z)-4-Carboxy-2-buten-1-yl]-3,5-dihydroxy-gamma-oxocyclopentanehexanoic Acid; (1R,2R,3S,5S)-2-[(2Z)-4-Carboxy-2-butenyl]-3,5-dihydroxy-gamma-oxocyclopentanehexanoic Acid; | 133161-96-3 | C16H24O7 | 328.36 | (1R,2R,3S,5S)-2-[(2Z)-4-Carboxy-2-buten-1-yl]-3,5-dihydroxy-gamma-oxocyclopentanehexanoic Acid; (1R,2R,3S,5S)-2-[(2Z)-4-Carboxy-2-butenyl]-3,5-dihydro... |
| PGD-M-13C3 | (1R,2R,3S,5S)-2-[(2Z)-4-Carboxy-2-buten-1-yl]-3,5-dihydroxy-gamma-oxocyclopentanehexanoic Acid-13C3; (1R,2R,3S,5S)-2-[(2Z)-4-Carboxy-2-butenyl]-3,5-dihydroxy-gamma-oxocyclopentanehexanoic Acid-13C3; | C13 13C3H24O7 | 331.34 | (1R,2R,3S,5S)-2-[(2Z)-4-Carboxy-2-buten-1-yl]-3,5-dihydroxy-gamma-oxocyclopentanehexanoic Acid-13C3; (1R,2R,3S,5S)-2-[(2Z)-4-Carboxy-2-butenyl]-3,5-di... | |
| PFI-4 | N-[2,3-Dihydro-1,3-dimethyl-2-oxo-6-(1-pyrrolidinyl)-1H-benzimidazol-5-yl]-2-methoxy-benzamide; | 900305-37-5 | C21H24N4O3 | 380.44 | N-[2,3-Dihydro-1,3-dimethyl-2-oxo-6-(1-pyrrolidinyl)-1H-benzimidazol-5-yl]-2-methoxy-benzamide;
|
| PFI-4-d6 | N-[2,3-Dihydro-1,3-dimethyl-2-oxo-6-(1-pyrrolidinyl)-1H-benzimidazol-5-yl]-2-methoxy-benzamide-d6 | C21H18D6N4O3 | 386.48 | N-[2,3-Dihydro-1,3-dimethyl-2-oxo-6-(1-pyrrolidinyl)-1H-benzimidazol-5-yl]-2-methoxy-benzamide-d6
| |
| (S)-PFI-2 Hydrochloride | 8-Fluoro-1,2,3,4-tetrahydro-N-[(1S)-2-oxo-2-(1-pyrrolidinyl)-1-[[3-(trifluoromethyl)phenyl]methyl]ethyl]-6-isoquinolinesulfonamide Hydrochloride; | 1627607-88-8 | C23H26ClF4N3O3S | 535.98 | 8-Fluoro-1,2,3,4-tetrahydro-N-[(1S)-2-oxo-2-(1-pyrrolidinyl)-1-[[3-(trifluoromethyl)phenyl]methyl]ethyl]-6-isoquinolinesulfonamide Hydrochloride;
|
| PFK 15 | 1-(4-Pyridinyl)-3-(2-quinolinyl)-2-propen-1-one; | 4382-63-2 | C17H12N2O | 260.29 | 1-(4-Pyridinyl)-3-(2-quinolinyl)-2-propen-1-one;
|
| PF9601N | 5-(Phenylmethoxy)-N-2-propyn-1-yl-1H-indole-2-methanamine; FA 73; | 133845-63-3 | C19H18N2O | 290.36 | 5-(Phenylmethoxy)-N-2-propyn-1-yl-1H-indole-2-methanamine; FA 73;
|
| PGE-M | (1R,2R,5R)-2-(2-Carboxyethyl)-5-hydroxy-epsilon,3-dioxocyclopentaneoctanoic Acid; (-)-7alpha-Hydroxy-5,11-diketotetranorprostan-1,16-dioic Acid; (-)-PGE2UM; 7-Hydroxy-5,11-diketotetranorprosta-1,16-dioic Acid; PGE2UM; | 24769-56-0 | C16H24O7 | 328.36 | (1R,2R,5R)-2-(2-Carboxyethyl)-5-hydroxy-epsilon,3-dioxocyclopentaneoctanoic Acid; (-)-7alpha-Hydroxy-5,11-diketotetranorprostan-1,16-dioic Acid; (-)-P... |
| PF-06291874 | N-[4-[(1S)-1-[3,5-Dimethyl-4-[4-(trifluoromethyl)-1H-pyrazol-1-yl]phenoxy]butyl]benzoyl]-beta-alanine; Glucagon Receptor Antagonists-4 | 1393124-08-7 | C26H28F3N3O4 | 503.51 | N-[4-[(1S)-1-[3,5-Dimethyl-4-[4-(trifluoromethyl)-1H-pyrazol-1-yl]phenoxy]butyl]benzoyl]-beta-alanine; Glucagon Receptor Antagonists-4
|
Page 3078 of 10017